DEXCOM INC. DL-,001/ US2521311074 /
6/14/2024 4:39:07 PM | Chg. +0.900 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
107.580EUR | +0.84% | 70 Turnover: 7,451.500 |
-Bid Size: - | -Ask Size: - | 43.07 bill.EUR | - | - |
GlobeNewswire
4/8
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
1/31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.